What are secondary findings from genetic testing?
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
Secondary findings are genetic test results that provide information about changes (variants) in a gene unrelated to the primary purpose for the testing.
Selecciones de videos para Understanding geneticsBiblioteca de videos
Resumen
Secondary findings are genetic test results that provide information about changes (variants) in a gene unrelated to the primary purpose for the testing.
When a clinician orders a genetic test to discover the genetic cause of a particular condition, the test will often sequence one or a few genes that seem most likely to be associated with that individual’s set of signs and symptoms. However, if the individual’s signs and symptoms do not have an obvious genetic cause, a clinician might order a test that sequences all of the pieces of an individual's DNA that provide instructions for making proteins (called an exome) or a test that sequences all of an individual’s DNA building blocks (nucleotides), called a genome. These tests are called whole exome sequencing and whole genome sequencing, respectivamente.
Many more genetic changes can be identified with whole exome and whole genome sequencing than by sequencing just one or a few genes. Sometimes, testing finds a variant that is associated with a condition other than the one for which testing was originally indicated. This is called a secondary finding. Some individuals with a secondary finding may not yet have any of the symptoms associated with the condition, but may be at risk of developing it later in life. For example, a person with a variant in the BRCA1
gene, which is associated with an increased risk of cáncer de mama y cáncer de ovario, may not have developed cancer. Other individuals with secondary findings may have a known medical condition, such as extremely high cholesterol, but receive results that indicate a genetic cause for that condition, such as a variant in the LDLR gene.
The American College of Medical Genetics and Genomics (ACMG) recommended that all labs performing whole exome and whole genome sequencing tests report particular secondary findings, in addition to any variants that are found related to the primary purpose of the testing. In the 2021 updated recommendations, ACMG proposed a list of 73 genes that are associated with a variety of conditions, from cancer to heart disease. The 73 genes for which secondary findings are reported were chosen because they are associated with conditions that have a definable set of clinical features, the possibility of early diagnosis, a reliable clinical genetic test, and effective intervention or treatment. The goal of reporting these secondary findings to an individual is to provide medical benefit by preventing or better managing health conditions. The variants that are reported are known to cause disease. Variants of unknown significance, whose involvement in disease at the current time is unclear, are not reported.
The information provided by secondary findings can be very important because it may help prevent a disease from occurring or guide the management of signs and symptoms if the disease develops or is already present. However, as with any type of medical diagnosis, the news of an unexpected potential health problem may lead to additional health costs and stress for individuals and their families. On the basis of secondary findings, additional testing to confirm results, ongoing screening tests, or preventive care may be advised. Individuals receiving whole exome or whole genome sequencing can choose to “opt out” of analysis of the 73 secondary finding genes and not receive variant results. As whole exome and whole genome sequencing become more common, it is important for individuals to understand what type of information they may learn and how it can impact their medical care.
Related patient information and medicines

Patient information leaflet
Enfermedad de Huntington
Huntington's disease is a genetically inherited condition that causes parts of el brain and nervous system to stop working properly over time. It is a slowly progressive condition that interferes with the movements of your body, thinking and judgement, and can lead to a change in your behaviour. S... Genetic testing Genetic testing is used to.

Patient information leaflet
Pruebas genéticas
Pruebas genéticas es a type of medical test that identifies changes in chromosomes, genes or proteins. Genético pruebas examine a person's DNA in a variety of ways to assess a person's genetic health. They are all designed to identify a particular gene that may cause a genetic disorder. What is genetic testing. Pruebas genéticas is a type of medical test.

Patient information leaflet
Fibrosis quística
Cystic fibrosis is an inherited disease which mainly affects the lungs and pancreas but can involve other organs. What causes cystic fibrosis. Cystic fibrosis is a genetic disorder. A genetic disorder es uno that can be passed encendido from tu parents through tu genes. ServiceUpsellPlaceholder Cystic fibrosis diagnosis Sweat test A doctor may.

Patient information leaflet
Albinismo
Albinism is a rare inherited (genetic) condition which reduces the amount of of melanin pigment in the skin, hair and/or eyes. People with albinism are often pale, with light-coloured irises. However, there are many types of albinism and people can be af... This can detect OCA type 1A but does not rule out other types of albinism. The most.

Patient information leaflet
Distrofia muscular
What is muscular dystrophy. Distrofia muscular (MD) is the name given to a group of disorders cuál cause progressive muscle weakness (meaning it gets worse over time). There are many different types of MD. The sample is examined under the microscope and the muscle chemicals (proteins) may be tested. Genetic analysis Genetic testing - this.

Patient information leaflet
Síndrome de Down
Down's syndrome (also known as Down syndrome) is a genetic chromosome problem. Someone with Down's syndrome has an extra copy of chromosome 21 in the cells of their body. All people with Down's syndrome have some degree of learning disability. There are two main prenatal diagnostic tests that can be done: amniocentesis and chorionic villus.
Lecturas adicionales y referencias
- What are secondary findings from genetic testing?; MedlinePlus, National Library of Medicine.
- Robert C. Green MD, MPH, Jonathan S. Berg MD, PhD, Wayne W. Grody MD, PhD, Sarah S. Kalia ScM, CGC, Bruce R. Korf MD, PhD, Christa L. Martin PhD, FACMG, Amy L. McGuire JD, PhD, Robert L. Nussbaum MD, Julianne M. O’Daniel MS, CGC, Kelly E. Ormond MS, CGC, Heidi L. Rehm PhD, FACMG, Michael S. Watson PhD, FACMG, Marc S. Williams MD, FACMG & Leslie G. Biesecker MD. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20. PubMed: 23788249. Free full-text article from PubMed Central: 3727274.
- Sarah S. Kalia ScM, Kathy Adelman, Sherri J. Bale PhD, Wendy K. Chung MD, PhD, Christine Eng MD, James P. Evans MD, PhD, Gail E. Herman MD, PhD, Sophia B. Hufnagel MD, Teri E. Klein PhD, Bruce R. Korf MD, PhD, Kent D. McKelvey MD, Kelly E. Ormond MS, C. Sue Richards PhD, Christopher N. Vlangos PhD, Michael Watson PhD, Christa L. Martin PhD & David T. Miller MD, PhD ; on behalf of the ACMG Secondary Findings Maintenance Working Group. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17. PubMed: 27854360.
- Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, Stewart DR, Amendola LM, Adelman K, Bale SJ, Gollob MH, Harrison SM, Hershberger RE, McKelvey K, Richards CS, Vlangos CN, Watson MS, Martin CL; ACMG Secondary Findings Working Group. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 May 20. doi: 10.1038/s41436-021-01172-3. Epub ahead of print. PMID: 34012068.
- Lee K, Abul-Husn NS, Amendola LM, Brothers KB, Chung WK, Gollob MH, Gordon AS, Harrison SM, Hershberger RE, Li M, Ondrasik D, Richards CS, Stergachis A, Stewart DR, Martin CL, Miller DT; ACMG Secondary Findings Working Group. Electronic address: documents@acmg.net. ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2025 Jun 23;27(8):101454. doi: 10.1016/j.gim.2025.101454. Epub ahead of print. PMID: 40568962.
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

